228 related articles for article (PubMed ID: 28116233)
1. Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry.
Nürnberger L; Gracien RM; Hok P; Hof SM; Rüb U; Steinmetz H; Hilker R; Klein JC; Deichmann R; Baudrexel S
Neuroimage Clin; 2017; 13():405-414. PubMed ID: 28116233
[TBL] [Abstract][Full Text] [Related]
2. Cortical thinning across Parkinson's disease stages and clinical correlates.
Wilson H; Niccolini F; Pellicano C; Politis M
J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
[TBL] [Abstract][Full Text] [Related]
4. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
5. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
[TBL] [Abstract][Full Text] [Related]
6. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study.
Gracien RM; Reitz SC; Hof SM; Fleischer V; Droby A; Wahl M; Steinmetz H; Groppa S; Deichmann R; Klein JC
J Magn Reson Imaging; 2017 Nov; 46(5):1485-1490. PubMed ID: 28240801
[TBL] [Abstract][Full Text] [Related]
8. Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia.
Zhang L; Wang M; Sterling NW; Lee EY; Eslinger PJ; Wagner D; Du G; Lewis MM; Truong Y; Bowman FD; Huang X
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):570-580. PubMed ID: 29610105
[TBL] [Abstract][Full Text] [Related]
9. Cortical structural involvement and cognitive dysfunction in early Parkinson's disease.
Klein JC; Rolinski M; Griffanti L; Szewczyk-Krolikowski K; Baig F; Ruffmann C; Groves AR; Menke RAL; Hu MT; Mackay C
NMR Biomed; 2018 Apr; 31(4):e3900. PubMed ID: 29436039
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of brain ageing: a quantitative longitudinal MRI study over 7 years.
Gracien RM; Nürnberger L; Hok P; Hof SM; Reitz SC; Rüb U; Steinmetz H; Hilker-Roggendorf R; Klein JC; Deichmann R; Baudrexel S
Eur Radiol; 2017 Apr; 27(4):1568-1576. PubMed ID: 27379992
[TBL] [Abstract][Full Text] [Related]
11. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
[TBL] [Abstract][Full Text] [Related]
12. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.
Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.
Schwarz ST; Mougin O; Xing Y; Blazejewska A; Bajaj N; Auer DP; Gowland P
Neuroimage Clin; 2018; 19():683-689. PubMed ID: 29872633
[TBL] [Abstract][Full Text] [Related]
14. Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients.
Lee EY; Sen S; Eslinger PJ; Wagner D; Shaffer ML; Kong L; Lewis MM; Du G; Huang X
Parkinsonism Relat Disord; 2013 Dec; 19(12):1088-93. PubMed ID: 23932064
[TBL] [Abstract][Full Text] [Related]
15. Cortical aging - new insights with multiparametric quantitative MRI.
Seiler A; Schöngrundner S; Stock B; Nöth U; Hattingen E; Steinmetz H; Klein JC; Baudrexel S; Wagner M; Deichmann R; Gracien RM
Aging (Albany NY); 2020 Aug; 12(16):16195-16210. PubMed ID: 32852283
[TBL] [Abstract][Full Text] [Related]
16. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
[TBL] [Abstract][Full Text] [Related]
17. Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
Gracien RM; Reitz SC; Hof SM; Fleischer V; Zimmermann H; Droby A; Steinmetz H; Zipp F; Deichmann R; Klein JC
Eur Radiol; 2016 Aug; 26(8):2578-86. PubMed ID: 26494641
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
Gorges M; Kunz MS; Müller HP; Liepelt-Scarfone I; Storch A; Dodel R; Hilker-Roggendorf R; ; Berg D; Kalbe E; Braak H; Del Tredici K; Baudrexel S; Huppertz HJ; Kassubek J
Hum Brain Mapp; 2020 Apr; 41(6):1416-1434. PubMed ID: 31789477
[TBL] [Abstract][Full Text] [Related]
19. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.
Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
Neurobiol Dis; 2019 Apr; 124():29-35. PubMed ID: 30408592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
